Literature DB >> 3033140

Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas.

L Banks, P Spence, E Androphy, N Hubbert, G Matlashewski, A Murray, L Crawford.   

Abstract

We recently reported the expression of human papillomavirus type 18 (HPV-18) E6 protein in bacteria and the production of anti-E6 polyclonal antibodies. This work has now been extended with the production of a panel of monoclonal antibodies against the HPV-18 E6 protein. These antibodies demonstrate that there is little antigenic conservation in the E6 protein between HPV-16 and HPV-18, with only one antibody recognizing a cross-reactive epitope. We have used both the monoclonal and the polyclonal antibodies to look for E6 expression in a number of HPV DNA-containing cell lines. These reagents specifically detected a 16.5K mol. wt. polypeptide in cells derived from a human cervical carcinoma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033140     DOI: 10.1099/0022-1317-68-5-1351

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  46 in total

1.  Negative regulation of Rb expression by the p53 gene product.

Authors:  Y Shiio; T Yamamoto; N Yamaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31.

Authors:  Choongho Lee; Laimonis A Laimins
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc.

Authors:  Xuefeng Liu; Aleksandra Dakic; Renxiang Chen; Gary L Disbrow; Yiyu Zhang; Yuhai Dai; Richard Schlegel
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

4.  HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function.

Authors:  Xuefeng Liu; Jeffrey Roberts; Aleksandra Dakic; Yiyu Zhang; Richard Schlegel
Journal:  Virology       Date:  2008-03-26       Impact factor: 3.616

5.  Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18.

Authors:  J B Hudson; M A Bedell; D J McCance; L A Laiminis
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

6.  Lymphoproliferative response to fusion proteins of human papillomaviruses in patients with cervical intraepithelial neoplasia.

Authors:  H A Cubie; M Norval; L Crawford; L Banks; T Crook
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

7.  Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype.

Authors:  P J Hurlin; P Kaur; P P Smith; N Perez-Reyes; R A Blanton; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

8.  Inhibition of p53 DNA binding by human papillomavirus E6 proteins.

Authors:  M S Lechner; L A Laimins
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Is HPV-18 present in human breast cancer cell lines?

Authors:  I Peran; A Riegel; Y Dai; R Schlegel; X Liu
Journal:  Br J Cancer       Date:  2010-04-20       Impact factor: 7.640

10.  The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells.

Authors:  S R Naidu; I M Love; A N Imbalzano; S R Grossman; E J Androphy
Journal:  Oncogene       Date:  2009-05-18       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.